Jose De Jesus Bravo Silva

Dr. Jose De Jesus Bravo Silva

Infectomics and Molecular Pathogenesis, CINVESTAV, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
RJRicardo Jimenez-Camacho
Ricardo Jimenez-Camacho
MBMagda Lizbeth Benítez-Vega
Magda Lizbeth Benítez-Vega
JHJonathan Hernández-Castillo
Jonathan Hernández-Castillo
CCCarlos Daniel Cordero-Rivera
Carlos Daniel Cordero-Rivera
Rosa Del AngelRosa Del Angel
Rosa Del Angel
Introduction: Zika virus (ZIKV) and dengue virus (DENV) are mosquito-borne flaviviruses associated with serious neurological complications, such as Guillain-Barré syndrome and congenital Zika syndrome (ZIKV), as well as encephalitis, meningitis, and stroke (DENV). Despite their growing public health impact in tropical regions, there are currently no specific treatments available. Both viruses modulate the RhoA GTPase pathway, which is involved in immune regulation and cytoskeletal dynamics. Melatonin, a hormone with antioxidant and immunomodulatory properties, has previously been shown to inhibit Japanese encephalitis virus (JEV) replication through RhoA pathway modulation.Methods: We evaluated the antiviral potential of melatonin against ZIKV and DENV-4 in vitro using U87-MG cells and in vivo using two mouse models: immunodeficient AG129 and neonatal immunocompetent CD1 mice. Antiviral and immunomodulatory effects were assessed by quantitative RT-PCR and analysis of inflammatory markers, including interferon-stimulated genes (MX1, IFI44L, IFN-β) and cytokines (IL-1β, TNF-α). Microglial activation and polarization were also analyzed in brain tissues.Results: Melatonin treatment significantly reduced ZIKV and DENV-4 replication and the associated inflammatory response in U87-MG cells. In AG129 mice, melatonin increased survival, attenuated clinical signs during DENV-4 infection, and reduced viral genome copies of both viruses. In neonatal CD1 mice, melatonin markedly decreased viral loads in the brain and suppressed inflammatory gene expression, microglial activation, and M1/M2 polarization imbalance.Discussion: Our findings demonstrate that melatonin exerts both antiviral and anti-inflammatory effects against ZIKV and DENV-4 infections in vitro and in vivo, likely through inhibition of the RhoA signaling pathway. These results suggest that melatonin is a promising therapeutic candidate for neuroinfections caused by flaviviruses.

23 August 2025 in European Journal of Pharmacology
Verified
Journal Article
Open access
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
CCCarlos Daniel Cordero-Rivera
Carlos Daniel Cordero-Rivera
MBMagda Lizbeth Benítez-Vega
Magda Lizbeth Benítez-Vega
JCJonathan Hernández Castillo
Jonathan Hernández Castillo
Rosa Del AngelRosa Del Angel
Rosa Del Angel
Dengue is a viral disease caused by the dengue virus (DENV), which continues to pose a significant global public health challenge. This concern is particularly heightened by the rising incidence of dengue over the last two decades. While many infected individuals experience mild symptoms, a subset can progress to severe dengue, characterized by life-threatening hemorrhagic complications. Addressing this critical public health issue requires the development of new, safe, and effective treatments. In this study, the therapeutic potential of various metformin and phenformin analogs against DENV infection was evaluated. The antiviral effect was assessed by measuring the percentage of infected cells, as well as the levels of viral proteins and infectious viral particles. Additionally, DENV-infected AG129 mice were treated with two selected analogs and monitored for survival, weight changes, clinical signs, and viral RNA copies. The results demonstrated that these analogs effectively inhibited the number of infected cells, reduced viral protein levels, and decreased the formation of infectious viral particles. Furthermore, when compared to metformin (MET), certain analogs exhibited enhanced antiviral efficacy. Notably, we also found that the antiviral activity of the analogs correlated with increased levels of phosphorylated AMPK (pAMPK). In vivo treatments yielded significant antiviral effects, as evidenced by reduced clinical symptoms, lower mortality rates compared to untreated controls, and a marked reduction in viral load. These findings underscore the potential of biguanides derivatives as promising therapeutic agents against dengue infection, providing a foundation for further exploration of their antiviral properties.

27 January 2026 in Emerging Microbes & Infections
Verified
Journal Article
Open access
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
MVMagda Lizbeth Benítez Vega
Magda Lizbeth Benítez Vega
SPSelvin Palacios
Selvin Palacios
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
Rosa Del AngelRosa Del Angel
Rosa Del Angel
Dengue, transmitted by Aedes mosquitoes, can progress to severe symptoms like hemorrhagic fever and shock syndrome. While the virus and host immune response contribute to severity, other factors, such as small extracellular vesicles (sEVs), may play a role. sEVs mediate intercellular communication by transferring cellular components; however, their role in vivo infection remains unclear. We isolated and characterized sEVs from DENV-infected C6/36 mosquito cells, finding that they interact with mammalian cells and internalize the content. Using sEVs populations (with a size between 100 and 200 nm), we demonstrated enhanced infection in in vitro and in vivo murine models, including immunocompetent and immunosuppressed mice, which developed severe dengue-like symptoms. Our study reveals that sEVs from DENV-infected mosquito cells contribute to dengue pathogenesis, inducing severe symptoms in in vivo models, highlighting their potential role in disease progression and severe outcomes.

29 September 2025 in Viruses
Verified
Journal Article
Open access
PDF file
MVMagda Lizbeth Benítez Vega
Magda Lizbeth Benítez Vega
CRCarlos Daniel Cordero Rivera
Carlos Daniel Cordero Rivera
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
RCRicardo Jiménez Camacho
Ricardo Jiménez Camacho
CMCarlos Noe Farfan Morales
Carlos Noe Farfan Morales
Rosa Del AngelRosa Del Angel
Rosa Del Angel
The cellular membrane is a dynamic structure composed of lipids and proteins organized into specialized domains that facilitate interactions between extracellular molecules and the intracellular environment. Tetraspanins are a family of transmembrane proteins involved in diverse cellular processes, including membrane stabilization and fusion, endocytosis, extracellular vesicle formation, and the organization of proteins and lipids at specific membrane sites known as Tetraspanin-Enriched Microdomains (TEMs). These lipid–protein interactions play a critical role in the replicative cycle of Orthoflavivirus, including dengue, Zika, and West Nile, by facilitating viral entry, replication, assembly, and egress. In addition, tetraspanins also regulate the biogenesis and function of extracellular vesicles, contributing to viral dissemination, persistent infection, and immune evasion. This review summarizes the current knowledge on the structural and functional aspects of tetraspanins, their interplay with lipids, and their emerging roles in the Orthoflavivirus replicative cycle. We also discuss how these insights may inform the development of antiviral strategies targeting membrane organization and virus–host interactions.

30 August 2024 in Veterinaria México OA
Verified
Journal Article
Open access
PDF file
Jose De Jesus Bravo SilvaJose De Jesus Bravo Silva
Jose De Jesus Bravo Silva
The meeting was organized by the Sociedad Mexicana de Virologia and involved the participation of 317 attendees from different education and investigation mexican institutes and from 5 countries. The scientific quality of the speakers was excellent and covered all issues and objectives of the meeting. A total of 37 oral presentations were presented in addition, there were two poster sessions with a total of 190 posters. At the different sessions we discussed the importance of the study of virology as an essential discipline whose approach under the One Health context requires intense and close collaboration between scientists, physicians, veterinarians, educators, and environmental health experts and government, which is crucial to face current and future challenges